𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TREATMENT OF REFRACTORY ACUTE LEUKAEMIA WITH HIGH DOSE CYTOSINE ARABINOSIDE

✍ Scribed by R. Willemze; F. E. Zwaan; J. J. Keuning; G. Colpin

Book ID
114709737
Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
120 KB
Volume
51
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of relapsed and refractory acu
Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide
✍ Martin Gore; Ray Powles; Anil Lakhani; Sarah Milan; Jennifer Maitland; Glen Goss πŸ“‚ Article πŸ“… 1989 πŸ› Springer 🌐 English βš– 425 KB

A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without an anthracycline. Complete remission rates for patients with relapsed or refractory acute myelogenous leukaemia (AML) were 15/25 (60%) and 1

Clofarabine and high-dose cytosine arabi
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 98 KB

Clofarabine (40Β mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2Β g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

High dose cytosine arabinoside (HDARAC)
High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance